Differences Between Beta-Blockers in Patients With Chronic Heart Failure and Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differences Between Beta-Blockers in Patients With Chronic Heart Failure and Chronic Obstructive Pulmonary Disease

Published:2010-04 Issue:17 Volume:55 Page:1780-1787
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Jabbour Andrew,Macdonald Peter S.,Keogh Anne M.,Kotlyar Eugene,Mellemkjaer Soren,Coleman Cathie F.,Elsik Maros,Krum Henry,Hayward Christopher S.

Funder

Pfizer Australia

AstraZeneca

Roche

Alpha-Pharma

Actelion

Myogen

Gilead

Pfizer

GlaxoSmithKline

Venragr

Heartware

Novartis

Bayer

Schering

Merck CSL

CSL Biotherapies

Merck

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure;Packer;N Engl J Med,1996

2. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF);Lancet,1999

3. The Cardiac Insufficiency Bisoprolol study II (CIBIS-II);Lancet,1999

4. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure;Le Jemtel;J Am Coll Cardiol,2007

5. Cardioselective beta-blockers for chronic obstructive pulmonary disease;Salpeter;Cochrane Database Syst Rev,2005

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eurasian Association of Cardiology (EAC)/ National Society of Heart Failure And Myocardial Disease (NSHFMD) guidelines for the diagnosis and treatment of chronic heart failure (2024);Eurasian heart journal;2024-05-27

2. Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease;Archivos de Bronconeumología;2024-04

3. Chronic Obstructive Pulmonary Disease in Heart Failure: Challenges in Diagnosis and Treatment for HFpEF and HFrEF;Current Heart Failure Reports;2024-03-28

4. Beta-blocker therapy among patients with heart failure;Pathophysiology, Risk Factors, and Management of Chronic Heart Failure;2024

5. Non‐cardiac comorbidities and intensive up‐titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG‐HF trial;European Journal of Heart Failure;2023-10-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3